On May 22, the Chinese University of Hong Kong (CUHK) released a research report stating that the risk of long COVID sequelae is related to an imbalance in gut bacteria. The university has developed an oral probiotic capsule formula that helps improve the symptoms of long COVID.
Previous research conducted by CUHK’s medical school revealed a close relationship between gut microbiota and long COVID sequelae. The research team invented the “SIM01” oral capsule formula and recruited 463 adults over 18 who had recovered from COVID-19 between 2021 and 2022. Approximately 70 percent of the participants were infected with the Omicron variant in 2022.
